Boothbay Fund Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.7M | Sell |
81,796
-404
| -0.5% | -$13.3K | 0.05% | 307 |
|
|
2025
Q1 | $3.3M | Sell |
82,200
-1,170
| -1% | -$47K | 0.09% | 238 |
|
|
2024
Q4 | $3.92M | Sell |
83,370
-7,347
| -8% | -$346K | 0.1% | 239 |
|
|
2024
Q3 | $4.79M | Sell |
90,717
-2,183
| -2% | -$115K | 0.11% | 217 |
|
|
2024
Q2 | $5.03M | Sell |
92,900
-2,979
| -3% | -$161K | 0.12% | 186 |
|
|
2024
Q1 | $6.72M | Buy |
95,879
+53,147
| +124% | +$3.73M | 0.13% | 126 |
|
|
2023
Q4 | $3.57M | Buy |
+42,732
| New | +$3.57M | 0.09% | 248 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1576 |
|
|
2023
Q2 | – | Sell |
-11,862
| Closed | -$417K | – | 1669 |
|
|
2023
Q1 | $417K | Buy |
+11,862
| New | +$417K | 0.01% | 1122 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1808 |
|
|
2022
Q3 | – | Sell |
-8,762
| Closed | -$344K | – | 2001 |
|
|
2022
Q2 | $344K | Buy |
+8,762
| New | +$344K | 0.01% | 1186 |
|
|
2021
Q3 | – | Sell |
-12,217
| Closed | -$242K | – | 1709 |
|
|
2021
Q2 | $242K | Sell |
12,217
-616
| -5% | -$12.2K | 0.01% | 1245 |
|
|
2021
Q1 | $298K | Sell |
12,833
-10,103
| -44% | -$235K | 0.01% | 979 |
|
|
2020
Q4 | $477K | Buy |
+22,936
| New | +$477K | 0.02% | 639 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 956 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 868 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 790 |
|
|
2019
Q4 | – | Sell |
-11,411
| Closed | -$130K | – | 770 |
|
|
2019
Q3 | $130K | Buy |
+11,411
| New | +$130K | 0.01% | 590 |
|
|
2018
Q3 | – | Sell |
-18,928
| Closed | -$157K | – | 688 |
|
|
2018
Q2 | $157K | Buy |
+18,928
| New | +$157K | 0.01% | 525 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 647 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 547 |
|